Shopping Cart 0
Cart Subtotal
AED 0

PeptiDream Inc (4587) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produce peptide libraries for the identification of highly potent and selective hit candidates. Its technologies include flexizyme; translation, cyclization, and peptide modifying technologies; and PD display. PeptiDream's technologies enables the production of peptide libraries for the development of peptide-based products. PeptiDreamoffers products for the treatment of Alzheimer's disease, amyotrophic lateral sclerosis, and others. The company collaborates with other biotechnology and drug development companies to receive contracts and research and development support funds, and target proteins. It also has its presence in Tokyo, Japan. PeptiDream is headquartered in Kawasaki, Japan.

PeptiDream Inc (4587)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PeptiDream Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

PeptiDream Inc, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

PeptiDream to Acquire Drug Discovery Research Business from PharmaDesign 12

Venture Financing 13

Modulus Discovery Raises USD7.2 Million in Series A Financing 13

Private Equity 14

Taiyo Pacific Partners Acquires Minority Stake in PeptiDream 14

Partnerships 15

PeptiDream Enters into Co-Development Agreement with Santen Pharma 15

Bayer and PeptiDream Enter into Partnership 16

PeptiDream and Kleo Pharma Enter into Co-Development Agreement 17

Heptares Therapeutics and PeptiDream Enter into Agreement 18

Sekisui Chemical, PeptiDream and Shionogi to Form Joint Venture 19

PeptiDream Enters into Agreement with Janssen Pharma 20

PeptiDream Enters into Research Agreement with BIND Therapeutics 21

PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 22

PeptiDream Enters into Agreement with Genentech 23

Kyorin Pharma Enters into Co-Development Agreement with PeptiDream 24

Teijin Pharma Enters into Discovery Agreement with PeptiDream 25

PeptiDream Enters into Discovery Agreement with Sanofi 26

PeptiDream Enters into Peptide Discovery Agreement with Merck 27

PeptiDream Expands Drug Discovery Agreement with Novartis 28

PeptiDream Enters into Agreement with Tokyo Metropolitan Institute of Medical Science 29

PeptiDream Enters Into Research Agreement With Ipsen To Discover Therapeutic Peptides 30

PeptiDream Expands Co-Development Agreement With Ipsen For Peptide Drugs 31

PeptiDream Expands Macrocylic Peptide Drug Discovery Agreement with Novartis 32

PeptiDream Enters into Drug Discovery Agreement with GlaxoSmithKline 33

PeptiDream Enters into Drug Discovery Agreement with Daiichi Sankyo 34

Licensing Agreements 35

Eli Lilly Enters into Licensing Agreement with PeptiDream 35

Shionogi Enters into Licensing Agreement with PeptiDream 36

PeptiDream Enters Into Licensing Agreement With Eli Lilly 37

Genentech Enters into Licensing Agreement with PeptiDream for PDPS Technology 38

PeptiDream Exercises Option for Licensing Agreement with Novartis 39

PeptiDream Enters Into Licensing Agreement With Bristol-Myers Squibb For Peptide Discovery Platform System 40

PeptiDream Expands Agreement With Bristol-Myers Squibb For Drug Discovery 41

Equity Offering 42

PeptiDream Raises USD53 Million in IPO 42

PeptiDream Inc-Key Competitors 43

PeptiDream Inc-Key Employees 44

PeptiDream Inc-Locations And Subsidiaries 45

Head Office 45

Other Locations & Subsidiaries 45

Recent Developments 46

Corporate Communications 46

Aug 22, 2017: PeptiDream Appoints Representative Directors 46

Government and Public Interest 47

Nov 09, 2017: PeptiDream Receives Grant to Discover and Develop Novel Therapeutics for Infectious Disease 47

Product News 48

Sep 25, 2017: PeptiDream and Kawasaki Medical School Announce Novel Muscle Atrophy Inhibitor for the Treatment of Duchenne Muscular Dystrophy 48

Other Significant Developments 49

Nov 13, 2017: PeptiDream Announces 2 nd Milestone from Macrocyclic Peptide Drug Discovery Alliance with Merck & Co., Inc., Kenilworth, N.J., U.S.A 49

Jun 06, 2017: PeptiDream Announces First Milestone from Macrocyclic Peptide Drug Discovery Alliance with Merck 50

Jun 06, 2017: PeptiDream Announces First Milestone from Macrocyclic Peptide Drug Discovery Alliance with Kyorin 51

May 31, 2017: PeptiDream Announces 5 th Milestone from Macrocyclic Peptide Drug Discovery Alliance with Bristol-Myers Squibb 52

Mar 22, 2017: PeptiDream Announces 1st Milestone from Macrocyclic Peptide Drug Discovery Alliance with Shionogi 53

Feb 14, 2017: PeptiDream Announces the Selection of Development Candidate from Discovery Collaboration with Daiichi Sankyo 54

Appendix 55

Methodology 55

About GlobalData 55

Contact Us 55

Disclaimer 55


List Of Figure

List of Figures

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

PeptiDream Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PeptiDream Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PeptiDream Inc, Deals By Therapy Area, 2012 to YTD 2018 9

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

PeptiDream to Acquire Drug Discovery Research Business from PharmaDesign 12

Modulus Discovery Raises USD7.2 Million in Series A Financing 13

Taiyo Pacific Partners Acquires Minority Stake in PeptiDream 14

PeptiDream Enters into Co-Development Agreement with Santen Pharma 15

Bayer and PeptiDream Enter into Partnership 16

PeptiDream and Kleo Pharma Enter into Co-Development Agreement 17

Heptares Therapeutics and PeptiDream Enter into Agreement 18

Sekisui Chemical, PeptiDream and Shionogi to Form Joint Venture 19

PeptiDream Enters into Agreement with Janssen Pharma 20

PeptiDream Enters into Research Agreement with BIND Therapeutics 21

PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 22

PeptiDream Enters into Agreement with Genentech 23

Kyorin Pharma Enters into Co-Development Agreement with PeptiDream 24

Teijin Pharma Enters into Discovery Agreement with PeptiDream 25

PeptiDream Enters into Discovery Agreement with Sanofi 26

PeptiDream Enters into Peptide Discovery Agreement with Merck 27

PeptiDream Expands Drug Discovery Agreement with Novartis 28

PeptiDream Enters into Agreement with Tokyo Metropolitan Institute of Medical Science 29

PeptiDream Enters Into Research Agreement With Ipsen To Discover Therapeutic Peptides 30

PeptiDream Expands Co-Development Agreement With Ipsen For Peptide Drugs 31

PeptiDream Expands Macrocylic Peptide Drug Discovery Agreement with Novartis 32

PeptiDream Enters into Drug Discovery Agreement with GlaxoSmithKline 33

PeptiDream Enters into Drug Discovery Agreement with Daiichi Sankyo 34

Eli Lilly Enters into Licensing Agreement with PeptiDream 35

Shionogi Enters into Licensing Agreement with PeptiDream 36

PeptiDream Enters Into Licensing Agreement With Eli Lilly 37

Genentech Enters into Licensing Agreement with PeptiDream for PDPS Technology 38

PeptiDream Exercises Option for Licensing Agreement with Novartis 39

PeptiDream Enters Into Licensing Agreement With Bristol-Myers Squibb For Peptide Discovery Platform System 40

PeptiDream Expands Agreement With Bristol-Myers Squibb For Drug Discovery 41

PeptiDream Raises USD53 Million in IPO 42

PeptiDream Inc, Key Competitors 43

PeptiDream Inc, Key Employees 44

PeptiDream Inc, Other Locations 45

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

PeptiDream Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

PeptiDream Inc (PeptiDream) is a biopharmaceutical company that discovers and develops constrained peptides, small molecule, and peptide-drug conjugate therapeutics. The company develops peptide discovery platform system (PDPS), a peptide generation and selection platform that helps to produce peptide libraries for the identification of highly potent and selective hit candidates. Its technologies include flexizyme; translation, cyclization, and peptide modifying technologies; and PD display. PeptiDream's technologies enables the production of peptide libraries for the development of peptide-based products. PeptiDreamoffers products for the treatment of Alzheimer's disease, amyotrophic lateral sclerosis, and others. The company collaborates with other biotechnology and drug development companies to receive contracts and research and development support funds, and target proteins. It also has its presence in Tokyo, Japan. PeptiDream is headquartered in Kawasaki, Japan.

PeptiDream Inc (4587)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PeptiDream Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

PeptiDream Inc, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

PeptiDream to Acquire Drug Discovery Research Business from PharmaDesign 12

Venture Financing 13

Modulus Discovery Raises USD7.2 Million in Series A Financing 13

Private Equity 14

Taiyo Pacific Partners Acquires Minority Stake in PeptiDream 14

Partnerships 15

PeptiDream Enters into Co-Development Agreement with Santen Pharma 15

Bayer and PeptiDream Enter into Partnership 16

PeptiDream and Kleo Pharma Enter into Co-Development Agreement 17

Heptares Therapeutics and PeptiDream Enter into Agreement 18

Sekisui Chemical, PeptiDream and Shionogi to Form Joint Venture 19

PeptiDream Enters into Agreement with Janssen Pharma 20

PeptiDream Enters into Research Agreement with BIND Therapeutics 21

PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 22

PeptiDream Enters into Agreement with Genentech 23

Kyorin Pharma Enters into Co-Development Agreement with PeptiDream 24

Teijin Pharma Enters into Discovery Agreement with PeptiDream 25

PeptiDream Enters into Discovery Agreement with Sanofi 26

PeptiDream Enters into Peptide Discovery Agreement with Merck 27

PeptiDream Expands Drug Discovery Agreement with Novartis 28

PeptiDream Enters into Agreement with Tokyo Metropolitan Institute of Medical Science 29

PeptiDream Enters Into Research Agreement With Ipsen To Discover Therapeutic Peptides 30

PeptiDream Expands Co-Development Agreement With Ipsen For Peptide Drugs 31

PeptiDream Expands Macrocylic Peptide Drug Discovery Agreement with Novartis 32

PeptiDream Enters into Drug Discovery Agreement with GlaxoSmithKline 33

PeptiDream Enters into Drug Discovery Agreement with Daiichi Sankyo 34

Licensing Agreements 35

Eli Lilly Enters into Licensing Agreement with PeptiDream 35

Shionogi Enters into Licensing Agreement with PeptiDream 36

PeptiDream Enters Into Licensing Agreement With Eli Lilly 37

Genentech Enters into Licensing Agreement with PeptiDream for PDPS Technology 38

PeptiDream Exercises Option for Licensing Agreement with Novartis 39

PeptiDream Enters Into Licensing Agreement With Bristol-Myers Squibb For Peptide Discovery Platform System 40

PeptiDream Expands Agreement With Bristol-Myers Squibb For Drug Discovery 41

Equity Offering 42

PeptiDream Raises USD53 Million in IPO 42

PeptiDream Inc-Key Competitors 43

PeptiDream Inc-Key Employees 44

PeptiDream Inc-Locations And Subsidiaries 45

Head Office 45

Other Locations & Subsidiaries 45

Recent Developments 46

Corporate Communications 46

Aug 22, 2017: PeptiDream Appoints Representative Directors 46

Government and Public Interest 47

Nov 09, 2017: PeptiDream Receives Grant to Discover and Develop Novel Therapeutics for Infectious Disease 47

Product News 48

Sep 25, 2017: PeptiDream and Kawasaki Medical School Announce Novel Muscle Atrophy Inhibitor for the Treatment of Duchenne Muscular Dystrophy 48

Other Significant Developments 49

Nov 13, 2017: PeptiDream Announces 2 nd Milestone from Macrocyclic Peptide Drug Discovery Alliance with Merck & Co., Inc., Kenilworth, N.J., U.S.A 49

Jun 06, 2017: PeptiDream Announces First Milestone from Macrocyclic Peptide Drug Discovery Alliance with Merck 50

Jun 06, 2017: PeptiDream Announces First Milestone from Macrocyclic Peptide Drug Discovery Alliance with Kyorin 51

May 31, 2017: PeptiDream Announces 5 th Milestone from Macrocyclic Peptide Drug Discovery Alliance with Bristol-Myers Squibb 52

Mar 22, 2017: PeptiDream Announces 1st Milestone from Macrocyclic Peptide Drug Discovery Alliance with Shionogi 53

Feb 14, 2017: PeptiDream Announces the Selection of Development Candidate from Discovery Collaboration with Daiichi Sankyo 54

Appendix 55

Methodology 55

About GlobalData 55

Contact Us 55

Disclaimer 55


List Of Figure

List of Figures

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9


List Of Table

List of Tables

PeptiDream Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

PeptiDream Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

PeptiDream Inc, Deals By Therapy Area, 2012 to YTD 2018 9

PeptiDream Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

PeptiDream to Acquire Drug Discovery Research Business from PharmaDesign 12

Modulus Discovery Raises USD7.2 Million in Series A Financing 13

Taiyo Pacific Partners Acquires Minority Stake in PeptiDream 14

PeptiDream Enters into Co-Development Agreement with Santen Pharma 15

Bayer and PeptiDream Enter into Partnership 16

PeptiDream and Kleo Pharma Enter into Co-Development Agreement 17

Heptares Therapeutics and PeptiDream Enter into Agreement 18

Sekisui Chemical, PeptiDream and Shionogi to Form Joint Venture 19

PeptiDream Enters into Agreement with Janssen Pharma 20

PeptiDream Enters into Research Agreement with BIND Therapeutics 21

PeptiDream Enters into Research Agreement with Asahi Kasei Pharma 22

PeptiDream Enters into Agreement with Genentech 23

Kyorin Pharma Enters into Co-Development Agreement with PeptiDream 24

Teijin Pharma Enters into Discovery Agreement with PeptiDream 25

PeptiDream Enters into Discovery Agreement with Sanofi 26

PeptiDream Enters into Peptide Discovery Agreement with Merck 27

PeptiDream Expands Drug Discovery Agreement with Novartis 28

PeptiDream Enters into Agreement with Tokyo Metropolitan Institute of Medical Science 29

PeptiDream Enters Into Research Agreement With Ipsen To Discover Therapeutic Peptides 30

PeptiDream Expands Co-Development Agreement With Ipsen For Peptide Drugs 31

PeptiDream Expands Macrocylic Peptide Drug Discovery Agreement with Novartis 32

PeptiDream Enters into Drug Discovery Agreement with GlaxoSmithKline 33

PeptiDream Enters into Drug Discovery Agreement with Daiichi Sankyo 34

Eli Lilly Enters into Licensing Agreement with PeptiDream 35

Shionogi Enters into Licensing Agreement with PeptiDream 36

PeptiDream Enters Into Licensing Agreement With Eli Lilly 37

Genentech Enters into Licensing Agreement with PeptiDream for PDPS Technology 38

PeptiDream Exercises Option for Licensing Agreement with Novartis 39

PeptiDream Enters Into Licensing Agreement With Bristol-Myers Squibb For Peptide Discovery Platform System 40

PeptiDream Expands Agreement With Bristol-Myers Squibb For Drug Discovery 41

PeptiDream Raises USD53 Million in IPO 42

PeptiDream Inc, Key Competitors 43

PeptiDream Inc, Key Employees 44

PeptiDream Inc, Other Locations 45

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

PeptiDream Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.